Willow Biosciences (TSE:WLLW) Hits New 52-Week Low – Should You Sell?

Willow Biosciences Inc. (TSE:WLLWGet Free Report) reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as C$0.03 and last traded at C$0.03, with a volume of 868386 shares trading hands. The stock had previously closed at C$0.04.

Willow Biosciences Price Performance

The stock’s 50 day simple moving average is C$0.07 and its 200-day simple moving average is C$0.09. The stock has a market capitalization of C$4.33 million, a price-to-earnings ratio of -0.50 and a beta of 1.13. The company has a debt-to-equity ratio of 131.61, a current ratio of 0.70 and a quick ratio of 19.71.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

See Also

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.